Cardiogenic Shock

Optimal Target MAP in Post-Cardiac Arrest AMI Shock

MAP between 80 and 100 mmHg Reduces Myocardial Injury Do blood pressure targets in the 36 hours after...
Cardiogenic Shock

Abiomed’s Cardiogenic Shock Guidelines


Cardiogenic Shock

Schäfer Paper on Impella® Heart Pump Use in AMI Cardiogenic Shock

Influence of Impella Treatment Timing and Predicted Risk on Mortality Prof. Andreas Schäfer, MD discu...
Digital Resources

Resource Library


Digital Resources

Practice Essentials


Online Education

Abiomed Academy


Protected PCI

SEE ALL

Cardiogenic Shock

SEE ALL

Newsletter

SUBSCRIBE

Upcoming Events


09.23.20
Harvi Hemodynamics Workshop for Fellows
09.23.20
Nursing Cardiogenic Shock Best Practices in the ICU
09.29.20
Impella in Surgery: Fellows & Early Career Webinar
09.30.20
Cardiogenic Shock Patient Identification

“This was a little bit interesting because, as you know, MitraClip is done exclusively from femoral venous access as is Impella RP.” Says Dr. Muhammad. Watch this case study, where he discusses the use of Impella RP and Impella 2.5 for MitraClip Procedure. bit.ly/2ZP5VO1 pic.twitter.com/RcjRbJ8pHm

From Protected PCI's Twitter

Today, #Impella 2.5 patient, Jim Hoag, celebrated five years of #heartrecovery. Read Jim's first person experience with Impella here: bit.ly/3ie1Km9 pic.twitter.com/kdp7PGEWpO

From Abiomed's Twitter